FRAT2 antibody (C-Term)
Quick Overview for FRAT2 antibody (C-Term) (ABIN184718)
Target
See all FRAT2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- C-Term
-
Purpose
- FRAT2 / GSK-3
-
Sequence
- GPDRIALQPS GSLL
-
Cross-Reactivity
- Human
-
Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence C-GPDRIALQPSGSLL, from the C Terminus of the protein sequence according to NP_036215.1.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Western Blot: Approx 30-35 kDa band seen in Human Heart lysate. Recommended for use at 1-3 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:2000.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- FRAT2 (Frequently Rearranged in Advanced T-Cell Lymphomas 2 (FRAT2))
-
Alternative Name
- FRAT2
-
Background
- FRAT2, GSK-3, frequently rearranged in advanced T-cell lymphomas 2, GSK-3 binding protein FRAT2, RP11-452K12.2, MGC10562
-
Gene ID
- 23401
-
NCBI Accession
- NP_036215
Target
-